Live prototype · seeded data · ‹ back to deck
Longevity · Network Command
MSO admin · v0.4 · forbventures.tli
ML
Network
Locations
Cohort outcomes
Recruitment
Compliance
Investor reporting
Research data
Active locations
14
+ 5 this quarter
Patients across network
3,184
2,142 in active treatment
Network revenue · MTD
$1.42M
$11.2M trailing 12 mo
Avg AHI improvement
63%
across 90-day cohorts
Series A readiness · Q4 view

87% to investor-grade.

on track
Audited unit economics complete
90-day cohort outcomes data complete
Franchise system documentation 95%
Compliance + audit (HIPAA, SOC 2) 88%
Apple AirPods integration scaffold 62%
Sabbagh / Mayo / Stanford advisory board 2 of 4 confirmed
Smeltzer warm-investor thread validating
Target raise
$25M
Pre-money
$120M
Comparable
10x
trailing 12-mo revenue
Franchisee recruitment

38 of 300 contacted

live
Reachable list
300
Outreach sent
152
Discovery call
96
Application
54
Signed
23
Live location
14
Conversion at every stage runs against the model. 8% contact-to-signed exceeds initial assumptions. Pipeline implies 24 live locations by Q4.
Locations

14 active · 5 onboarding · 4 in build

Location Tenant ID Patients MTD revenue Avg AHI delta RCM clean Compliance Status
Sleep Cycle Center · Austin (flagship)
Dr. Chad Denman
 ATX-001 412 $214K -68% 97% healthy
Sleep Cycle Center · Austin North
Dr. Chad Denman
 ATX-002 284 $152K -61% 94% healthy
Hill Country Sleep & Dental
Dr. Reena Patel
 ATX-014 87 $74K -58% 94% healthy
Restful Smile Center · Dallas
Dr. James Kuo
 DAL-003 312 $181K -64% 96% healthy
Lone Star Sleep Solutions · Houston
Dr. Nicole Bernard
 HOU-005 198 $112K -62% 92% CPOM review
Highland Park Sleep · Dallas
Dr. Ravi Mehra
 DAL-008 156 $92K -60% 93% healthy
Phoenix Sleep Group
Dr. Maria Acosta
 PHX-009 134 $78K -66% 95% healthy
Twin Cities Sleep Dental
Dr. Eric Lindstrom
 MSP-011 97 $58K -55% 91% RCM lag
Cascade Sleep · Portland, OR
Dr. Linda Gao
 PDX-012 71 $41K -52% 89% healthy
Coastal Sleep Center · San Diego
Dr. Aaron Park
 SAN-013 142 $84K -67% 96% healthy
+ 4 onboarding · 4 in build
90-day cohort outcomes

By treatment modality

CPAP · n=1,184 -72% AHI
90-day adherence 71% · payor threshold cleared
Oral appliance · n=741 -58% AHI
Compliance 92% · highest patient satisfaction
Combination therapy · n=148 -81% AHI
Severe-only · highest outcome efficacy
Weight loss + epigenetic · n=69 -44% AHI
Adjunct only · early data
Cross-disease signal

Patient referrals to TLI specialist network

90 days
Specialty Trigger Referrals Conversion
Cardiology Nocturnal BP > 140/90 184 62%
Endocrinology CGM correlation r > 0.6 97 71%
Neurology / cognitive Deep sleep < 1h, 3-night avg 52 38%
Pulmonology SpO2 < 88% > 5% of night 128 68%
Mental health PHQ-9 + sleep correlation 74 52%
Sabbagh advisory · cohort building
52 cognitive-flagged patients consented to research dataset for the Alzheimer's-sleep correlation study. First analyzable cohort in Q1 2027.
Compliance & audit

All systems clean. One state under review.

Healthy
HIPAA
BAAs current at 14 of 14. Access ledger complete.
Healthy
SOC 2 Type 1
Initial audit Q3. Type 2 attest. window opens Q1 2027.
Review
CPOM · TX
MSO management agreement under counsel review for Houston location.
Healthy
Anti-kickback / Stark
Referral structure passes safe-harbor analysis (Hal Katz, Husch).
AI clinical coach · physician-in-the-loop

Every recommendation crosses a physician's desk before a patient sees it.

Advisory-board guardrails · auditable · network-wide
guardrails active v0.7.2
Interaction alerts · 90d
327
14 prevented hospitalizations (est.)
Drafts generated · 24h
1,284
across 14 locations
Physician approved
87%
1,117 sent to patients
Edited before send
9%
116, feeds retraining
Rejected
4%
51, with reason logged

Live queue · last 6 actions

refreshes 30s
SCC Austin · Dr. Denman approved interaction alert (Berberine + Wegovy)
Patient RD-2841 · routed to PCP · 06:42 AM
approved
SCC Plano · Dr. Vasquez edited oral-appliance compliance message
Tone, then approved · 06:38 AM
edited
SCC Scottsdale · NP Reyes approved Vit D dosing nudge
Standing-order protocol · 06:31 AM
approved
SCC Houston · Dr. Patel rejected GLP-1 dose suggestion
Reason: out-of-scope without endo consult · logged · 06:24 AM
rejected
SCC Austin · Dr. Denman approved lab pattern read (HbA1c + apnea)
No edits · 06:18 AM
approved
SCC Plano · Dr. Vasquez edited CGM trend interpretation
Reframed for patient literacy · 06:11 AM
edited

Guardrails in force

  • ●Model reads, does not diagnose. Every recommendation labeled as interpretation.
  • ●Patient never sees output until a credentialed physician approves or edits.
  • ●Refusal patterns reviewed quarterly by Sabbagh / Mayo / Stanford advisory.
  • ●Every prompt, output, and physician edit is logged with timestamp and signer.
  • ●Drug and supplement interactions sourced from Lexicomp, First Databank, NIH RxNorm.
  • ●Rejections are training data. Edit deltas feed weekly model alignment review.
Research arm · TLI Network

A defensible, HIPAA-clean monetization layer.

Patient-consented, cohort-aggregated, committee-reviewed.
12 partners 3 grants pending
Consented patients
2,418
76% of active network
Active studies
9
3 IRB-supervised, 6 industry
License revenue · YTD
$1.84M
$4.6M projected full year
Patient credits issued
$184K
10% revenue share to participants

Active studies

Apnea severity and HbA1c trajectory in pre-diabetic adults
UT Southwestern
IRB approved · cohort n=812 · 12-month longitudinal · grant funded
Oral appliance compliance and overnight HRV recovery
Mayo Sleep
IRB approved · cohort n=1,204 · 24-month · co-publication planned Q3
GLP-1 RA effects on AHI in obese OSA patients
Industry · pharma
Industry license · cohort n=486 · de-identified · DUC approved Apr 22
Epigenetic age and treated vs. untreated sleep apnea
Stanford Longevity
Grant pending · cohort n=2,100 expected · DunedinPACE

Data Use Committee

Every external license request is reviewed by the DUC before any cohort leaves the platform. De-identification is verified against HIPAA Safe Harbor and Expert Determination.

In review 4
Approved YTD 23
Denied YTD 6
Median time to decision 9 days
Chair
Dr. Marwan Sabbagh, MD
Scientific Advisory Board